• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

肠内补充花生四烯酸和二十二碳六烯酸与极早产儿肺结局的关系。

Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants.

机构信息

Karolinska Institutet, Department of Clinical Science, Intervention and Technology (CLINTEC), Stockholm, Sweden; Division of Neonatology, Department of Pediatrics, University Medical Center of the Johannes Gutenberg-University Mainz, Mainz, Germany.

Department of Clinical Neuroscience, Institute of Neuroscience and Physiology, Sahlgrenska Academy, University of Gothenburg, Gothenburg, Sweden.

出版信息

Prostaglandins Leukot Essent Fatty Acids. 2024 Feb;201:102613. doi: 10.1016/j.plefa.2024.102613. Epub 2024 Feb 15.

DOI:10.1016/j.plefa.2024.102613
PMID:38377640
Abstract

Enteral supplementation with arachidonic acid (AA) and docosahexaenoic acid (DHA) in extremely preterm infants has shown beneficial effects on retinopathy of prematurity and pulmonary outcome whereas exclusive DHA supplementation has been associated with increased pulmonary morbidity. This secondary analysis evaluates pulmonary outcome in 204 extremely preterm infants, randomized to receive AA (100 mg/kg/day) and DHA (50 mg/kg/day) enterally from birth until term age or standard care. Pulmonary morbidity was primarily assessed based on severity of bronchopulmonary dysplasia (BPD). Serum levels of AA and DHA during the first 28 days were analysed in relation to BPD. Supplementation with AA:DHA was not associated with increased BPD severity, adjusted OR 1.48 (95 % CI 0.85-2.61), nor with increased need for respiratory support at post menstrual age 36 weeks or duration of oxygen supplementation. Every 1 % increase in AA was associated with a reduction of BPD severity, adjusted OR 0.73 (95 % CI 0.58-0.92). In conclusion, in this study, with limited statistical power, enteral supplementation with AA:DHA was not associated with an increased risk of pulmonary morbidity, but higher levels of AA were associated with less severe BPD. Whether AA or the combination of AA and DHA have beneficial roles in the immature lung needs further research.

摘要

肠内补充花生四烯酸(AA)和二十二碳六烯酸(DHA)可使极早产儿的视网膜病变和肺结局受益,而单独补充 DHA 与肺发病率增加有关。这项二次分析评估了 204 名极早产儿的肺结局,他们随机接受 AA(100mg/kg/天)和 DHA(50mg/kg/天)从出生到足月年龄或标准护理的肠内补充。肺发病率主要根据支气管肺发育不良(BPD)的严重程度进行评估。分析了前 28 天内血清 AA 和 DHA 水平与 BPD 的关系。AA:DHA 的补充与 BPD 严重程度的增加无关,调整后的 OR 为 1.48(95 % CI 0.85-2.61),也与出生后月经年龄 36 周时呼吸支持的需求或氧补充的持续时间无关。AA 每增加 1 %,BPD 严重程度降低,调整后的 OR 为 0.73(95 % CI 0.58-0.92)。总之,在这项研究中,由于统计能力有限,AA:DHA 的肠内补充与肺发病率的增加无关,但 AA 水平较高与 BPD 较轻有关。AA 或 AA 和 DHA 的组合是否对未成熟的肺有有益作用需要进一步研究。

相似文献

1
Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants.肠内补充花生四烯酸和二十二碳六烯酸与极早产儿肺结局的关系。
Prostaglandins Leukot Essent Fatty Acids. 2024 Feb;201:102613. doi: 10.1016/j.plefa.2024.102613. Epub 2024 Feb 15.
2
Effect of Enteral Lipid Supplement on Severe Retinopathy of Prematurity: A Randomized Clinical Trial.肠内脂质补充对严重早产儿视网膜病变的影响:一项随机临床试验。
JAMA Pediatr. 2021 Apr 1;175(4):359-367. doi: 10.1001/jamapediatrics.2020.5653.
3
The N3RO trial: a randomised controlled trial of docosahexaenoic acid to reduce bronchopulmonary dysplasia in preterm infants < 29 weeks' gestation.N3RO试验:一项关于二十二碳六烯酸降低孕周<29周早产儿支气管肺发育不良的随机对照试验。
BMC Pediatr. 2016 Jun 1;16:72. doi: 10.1186/s12887-016-0611-0.
4
Effect of arachidonic and docosahexaenoic acid supplementation on respiratory outcomes and neonatal morbidities in preterm infants.补充花生四烯酸和二十二碳六烯酸对早产儿呼吸结局和新生儿发病率的影响。
Clin Nutr. 2023 Jan;42(1):22-28. doi: 10.1016/j.clnu.2022.11.012. Epub 2022 Nov 17.
5
Association Between Enteral Supplementation With High-Dose Docosahexaenoic Acid and Risk of Bronchopulmonary Dysplasia in Preterm Infants: A Systematic Review and Meta-analysis.高剂量二十二碳六烯酸肠内补充与早产儿支气管肺发育不良风险的关系:系统评价和荟萃分析。
JAMA Netw Open. 2023 Mar 1;6(3):e233934. doi: 10.1001/jamanetworkopen.2023.3934.
6
Modification of serum fatty acids in preterm infants by parenteral lipids and enteral docosahexaenoic acid/arachidonic acid: A secondary analysis of the Mega Donna Mega trial.肠外脂肪和肠内二十二碳六烯酸/花生四烯酸对早产儿血清脂肪酸的影响:Mega Donna Mega 试验的二次分析。
Clin Nutr. 2023 Jun;42(6):962-971. doi: 10.1016/j.clnu.2023.04.020. Epub 2023 Apr 17.
7
Arachidonic acid and docosahexaenoic acid levels correlate with the inflammation proteome in extremely preterm infants.花生四烯酸和二十二碳六烯酸水平与极早产儿的炎症蛋白质组相关。
Clin Nutr. 2024 May;43(5):1162-1170. doi: 10.1016/j.clnu.2024.03.031. Epub 2024 Apr 3.
8
Enteral supplementation with high-dose docosahexaenoic acid on the risk of bronchopulmonary dysplasia in very preterm infants: a collaborative study protocol for an individual participant data meta-analysis.肠内补充高剂量二十二碳六烯酸对极早产儿支气管肺发育不良风险的影响:一项个体参与者数据荟萃分析的合作研究方案。
BMJ Open. 2023 Jul 30;13(7):e076223. doi: 10.1136/bmjopen-2023-076223.
9
Effect of Maternal Docosahexaenoic Acid Supplementation on Bronchopulmonary Dysplasia-Free Survival in Breastfed Preterm Infants: A Randomized Clinical Trial.母亲二十二碳六烯酸补充对母乳喂养早产儿支气管肺发育不良无生存影响的随机临床试验。
JAMA. 2020 Jul 14;324(2):157-167. doi: 10.1001/jama.2020.8896.
10
Association of Docosahexaenoic Acid and Arachidonic Acid Serum Levels With Retinopathy of Prematurity in Preterm Infants.二十二碳六烯酸和花生四烯酸血清水平与早产儿视网膜病变的关系。
JAMA Netw Open. 2021 Oct 1;4(10):e2128771. doi: 10.1001/jamanetworkopen.2021.28771.

引用本文的文献

1
Can prenatal conditions impact the effect of omega-3 on bronchopulmonary dysplasia in very preterm infants? A secondary analysis of a randomized controlled trial.产前状况会影响ω-3对极早产儿支气管肺发育不良的疗效吗?一项随机对照试验的二次分析。
Eur J Pediatr. 2025 Mar 12;184(4):243. doi: 10.1007/s00431-025-06053-4.
2
Efficacy and Safety of Prophylactic Agents in Prevention of Retinopathy of Prematurity: A Systematic Review and Meta-analysis of Randomised Controlled rials.预防性药物预防早产儿视网膜病变的疗效和安全性:随机对照试验的系统评价和荟萃分析
BMJ Open Ophthalmol. 2024 Dec 25;9(1):e001910. doi: 10.1136/bmjophth-2024-001910.